New COVID studies show promise for the Johnson & Johnson vaccine booster
Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant.
by Joe Palca
Dec 30, 2021
1 minute
Two new studies of a Johnson & Johnson COVID-19 vaccine booster showed promise against the omicron variant at a time when public health officials are urgently recommending booster shots against the
You’re reading a preview, subscribe to read more.
Start your free 30 days